The safety of Vidalista 80 is evaluated by two main groups: 1. Regulatory Authorities Before any prescription drug can be legally marketed, its safety, quality, and efficacy must be assessed by the country’s drug regulatory agency: In India, where Vidalista is manufactured, the Central Drugs Standard Control Organization (CDSCO) oversees approval and sets safety standards. In other countries, equivalent agencies like the FDA (USA), MHRA (UK), or TGA (Australia) perform similar roles for drugs sold in their markets. Note: Vidalista 80 specifically may not be officially approved in some countries, so its evaluation is primarily by Indian authorities and by manufacturers following local regulations. 2. Healthcare Professionals Even after regulatory review, the safety for an individual patient is assessed by doctors or qualified healthcare providers. They consider factors like: Age and overall health Cardiovascular conditions Other medications (to prevent harmful interactions) Proper dosing for effectiveness and minimal side effects The drug’s manufacturing safety is overseen by regulatory agencies, while its use in a patient is evaluated by a healthcare professional.